{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:42:16Z","timestamp":1788910936141,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40618-015-0326-3","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T12:32:34Z","timestamp":1435062754000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"39","author":[{"given":"V.","family":"Akbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Hendijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Varshosaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Fakhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Morshedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"issue":"Supplement 1","key":"326_CR1","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2337\/dc13-S067","volume":"36","author":"AD Association","year":"2013","unstructured":"Association AD (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Supplement 1):S67\u2013S74","journal-title":"Diabetes Care"},{"key":"326_CR2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/978-1-4614-5441-0_6","volume-title":"Diabetes","author":"E Ginter","year":"2013","unstructured":"Ginter E, Simko V (2013) Type 2 diabetes mellitus, pandemic in 21st century. Diabetes. Springer, New York, pp 42\u201350"},{"key":"326_CR3","unstructured":"http:\/\/www.idf.org\/diabetesatlas . Accessed 7 Apr 2015"},{"key":"326_CR4","first-page":"1","volume-title":"Diabetes","author":"K Kaul","year":"2013","unstructured":"Kaul K et al (2013) Introduction to diabetes mellitus. Diabetes. Springer, New York, pp 1\u201311"},{"issue":"8","key":"326_CR5","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/diacare.26.8.2231","volume":"26","author":"M Alvarsson","year":"2003","unstructured":"Alvarsson M et al (2003) Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care 26(8):2231\u20132237","journal-title":"Diabetes Care"},{"issue":"4","key":"326_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/pdi.1960140404","volume":"14","author":"R Hanas","year":"1997","unstructured":"Hanas R, Ludvigsson J (1997) Experience of pain from insulin injections and needle-phobia in young patients with IDDM. Pract Diabetes Int 14(4):95\u201399","journal-title":"Pract Diabetes Int"},{"key":"326_CR7","first-page":"219","volume":"62","author":"A Marble","year":"1949","unstructured":"Marble A, Renold A (1949) Atrophy and hypertrophy of subcutaneous fat due to insulin. Trans Assoc Am Physicians 62:219","journal-title":"Trans Assoc Am Physicians"},{"issue":"3","key":"326_CR8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2008-1415","volume":"94","author":"MM Fatourechi","year":"2009","unstructured":"Fatourechi MM et al (2009) Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 94(3):729\u2013740","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"326_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/diacare.27.1.239","volume":"27","author":"WT Cefalu","year":"2004","unstructured":"Cefalu WT (2004) Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care 27(1):239\u2013246","journal-title":"Diabetes Care"},{"issue":"6","key":"326_CR10","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diabetes.51.6.1663","volume":"51","author":"S Satake","year":"2002","unstructured":"Satake S et al (2002) Direct and indirect effects of insulin on glucose uptake and storage by the liver. Diabetes 51(6):1663\u20131671","journal-title":"Diabetes"},{"issue":"7","key":"326_CR11","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2337\/dc11-0523","volume":"34","author":"K Vehik","year":"2011","unstructured":"Vehik K et al (2011) Long-term outcome of individuals treated with oral insulin diabetes prevention trial-type 1 (DPT-1) oral insulin trial. Diabetes Care 34(7):1585\u20131590","journal-title":"Diabetes Care"},{"issue":"2","key":"326_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1211\/0022357055434","volume":"57","author":"ME Lane","year":"2005","unstructured":"Lane ME, O\u2019Driscoll CM, Corrigan OI (2005) Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model. J Pharm Pharmacol 57(2):169\u2013175","journal-title":"J Pharm Pharmacol"},{"issue":"14","key":"326_CR13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0142-9612(00)00039-9","volume":"21","author":"MK Marsch\u00fctz","year":"2000","unstructured":"Marsch\u00fctz MK, Bernkop-Schn\u00fcrch A (2000) Oral peptide drug delivery: polymer\u2013inhibitor conjugates protecting insulin from enzymatic degradation in vitro. Biomaterials 21(14):1499\u20131507","journal-title":"Biomaterials"},{"issue":"3","key":"326_CR14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jconrel.2004.10.032","volume":"102","author":"B-Y Kim","year":"2005","unstructured":"Kim B-Y et al (2005) Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin\u2014microparticle conjugates in oral insulin delivery system. J Controll Release 102(3):525\u2013538","journal-title":"J Controll Release"},{"issue":"1","key":"326_CR15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2005.04.016","volume":"298","author":"A Cilek","year":"2005","unstructured":"Cilek A et al (2005) A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int J Pharm 298(1):176\u2013185","journal-title":"Int J Pharm"},{"issue":"2","key":"326_CR16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0022-3565(24)38943-8","volume":"295","author":"CQ Xia","year":"2000","unstructured":"Xia CQ, Wang J, Shen W-C (2000) Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 295(2):594\u2013600","journal-title":"J Pharmacol Exp Ther"},{"issue":"S1","key":"326_CR17","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/dmrr.207","volume":"18","author":"J Gordon Still","year":"2002","unstructured":"Gordon Still J (2002) Development of oral insulin: progress and current status. Diabetes\/Metabol Res Rev 18(S1):S29\u2013S37","journal-title":"Diabetes\/Metabol Res Rev"},{"issue":"2","key":"326_CR18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2337\/diacare.26.2.421","volume":"26","author":"M Kipnes","year":"2003","unstructured":"Kipnes M et al (2003) Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes. Diabetes Care 26(2):421\u2013426","journal-title":"Diabetes Care"},{"issue":"7","key":"326_CR19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.metabol.2005.02.008","volume":"54","author":"P Pozzilli","year":"2005","unstructured":"Pozzilli P et al (2005) Biokinetics of buccal spray insulin in patients with type 1 diabetes. Metab Clin Exp 54(7):930\u2013934","journal-title":"Metab Clin Exp"},{"key":"326_CR20","unstructured":"Schwartz S et al. (2008) A two-week randomized active comparator study of two HDV-insulin routes (SC and oral) and SC human insulin in patients with type 1 diabetes mellitus (417-P). In: Poster session presented at: 68th annual American diabetes association meeting"},{"issue":"4","key":"326_CR21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269","journal-title":"Ann Intern Med"},{"key":"326_CR22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/9780470712184.ch7","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JP Higgins","year":"2008","unstructured":"Higgins JP, Deeks JJ (2008) Selecting studies and collecting data. In: Higgins JP, Green S (eds) Cochrane handbook for systematic reviews of interventions. Wiley, England, pp 151\u2013190"},{"key":"326_CR23","first-page":"8.1","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DJ, Sterne JA (2011) Assessing risk of bias in included studies. In: Higgins JP, Green S (eds) Cochrane handbook for systematic reviews of interventions. Wiley, England, pp 8.1\u20138.54"},{"key":"326_CR24","volume-title":"Practical meta-analysis","author":"MW Lipsey","year":"2001","unstructured":"Lipsey MW, Wilson DB (2001) Practical meta-analysis. SAGE Publications, London"},{"issue":"11","key":"326_CR25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"1","key":"326_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1536867X0800800102","volume":"8","author":"R Harris","year":"2008","unstructured":"Harris R et al (2008) Metan: fixed- and random-effects meta-analysis. Stata J 8(1):3\u201328","journal-title":"Stata J"},{"issue":"8","key":"326_CR27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1503\/cmaj.060410","volume":"176","author":"JP Ioannidis","year":"2007","unstructured":"Ioannidis JP, Trikalinos TA (2007) The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 176(8):1091\u20131096","journal-title":"CMAJ"},{"issue":"1","key":"326_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/152091504322783341","volume":"6","author":"J Guevara-Aguirre","year":"2004","unstructured":"Guevara-Aguirre J et al (2004) Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents. Diabetes Technol Ther 6(1):1\u20138","journal-title":"Diabetes Technol Ther"},{"issue":"9229","key":"326_CR29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(00)02579-4","volume":"356","author":"L Chaillous","year":"2000","unstructured":"Chaillous L et al (2000) Oral insulin administration and residual \u03b2-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Lancet 356(9229):545\u2013549","journal-title":"Lancet"},{"issue":"8","key":"326_CR30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s001250051482","volume":"43","author":"P Pozzilli","year":"2000","unstructured":"Pozzilli P et al (2000) No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII). Diabetologia 43(8):1000\u20131004","journal-title":"Diabetologia"},{"key":"326_CR31","first-page":"313","volume":"52","author":"YW Cho","year":"2000","unstructured":"Cho YW, Hsu FL (2000) Reactivating glyburide in a group of sulfonylurea tolerating and non-responding type 2 diabetics with the iso-oral insulin and isoglysulin. Chin Pharm J 52(6):313\u2013324","journal-title":"Chin Pharm J"},{"key":"326_CR32","doi-asserted-by":"crossref","unstructured":"Ergun-Longmire B et al. (2004) Oral insulin therapy to prevent progression of immune-mediated (Type 1) diabetes. Ann N Y Acad Sci 1029:260\u2013277","DOI":"10.1196\/annals.1309.057"},{"issue":"4","key":"326_CR33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/152091502760306544","volume":"4","author":"S Clement","year":"2002","unstructured":"Clement S et al (2002) Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Ther 4(4):459\u2013466","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"326_CR34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1463-1326.2010.01213.x","volume":"12","author":"A Khedkar","year":"2010","unstructured":"Khedkar A et al (2010) A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects. Diabetes Obes Metab 12(8):659\u2013664","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"326_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2003.07.021","volume":"53","author":"S Clement","year":"2004","unstructured":"Clement S et al (2004) Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I\/II clinical trial. Metabol-Clin Exp 53(1):54\u201358","journal-title":"Metabol-Clin Exp"},{"issue":"4","key":"326_CR36","doi-asserted-by":"crossref","first-page":"e59524","DOI":"10.1371\/journal.pone.0059524","volume":"8","author":"R Eldor","year":"2013","unstructured":"Eldor R et al (2013) Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study. PLoS One 8(4):e59524","journal-title":"PLoS One"},{"issue":"5","key":"326_CR37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1172\/JCI101175","volume":"19","author":"J Murlin","year":"1940","unstructured":"Murlin J et al (1940) Effectiveness of per-oral insulin in human diabetes. J Clin Investig 19(5):709","journal-title":"J Clin Investig"},{"issue":"8762","key":"326_CR38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0140-6736(91)90448-X","volume":"338","author":"BM Singh","year":"1991","unstructured":"Singh BM et al (1991) Detection of glibenclamide in oral insulin capsules [2]. Lancet 338(8762):308\u2013310","journal-title":"Lancet"},{"issue":"1","key":"326_CR39","first-page":"32","volume":"83","author":"A Grigor\u2019ev","year":"2005","unstructured":"Grigor\u2019ev A et al (2005) To the question of the possibility of oral insulin administration. Klin Med 83(1):32","journal-title":"Klin Med"},{"key":"326_CR40","first-page":"1","volume":"9","author":"Z Annabestani","year":"2010","unstructured":"Annabestani Z et al (2010) Insulin buccal spray (Oral-Lyn) efficacy in Type 1 diabetes. Iranian J Diabetes Lipid Disord 9:1\u20134","journal-title":"Iranian J Diabetes Lipid Disord"},{"issue":"4","key":"326_CR41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/dia.2006.0019","volume":"9","author":"J Guevara-Aguirre","year":"2007","unstructured":"Guevara-Aguirre J et al (2007) Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes. Diabetes Technol Ther 9(4):372\u2013376","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"326_CR42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/dmrr.477","volume":"20","author":"J Guevara-Aguirre","year":"2004","unstructured":"Guevara-Aguirre J et al (2004) Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study. Diabetes-Metabol Res Rev 20(6):472\u2013478","journal-title":"Diabetes-Metabol Res Rev"},{"key":"326_CR43","unstructured":"Generex Oral-lyn\u2122 (2013) Results in more rapid reductions of HbA1c in Shreya\u2019s phase III study of type 2 diabetes in India. Available from: http:\/\/investor.generex.com\/releasedetail.cfm?ReleaseID=776114 . Accessed 22 Aug 2014"},{"issue":"6","key":"326_CR44","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/diacare.28.6.1353","volume":"28","author":"S Cernea","year":"2005","unstructured":"Cernea S et al (2005) Dose-response relationship of oral insulin spray in healthy subjects. Diabetes Care 28(6):1353\u20131357","journal-title":"Diabetes Care"},{"issue":"6","key":"326_CR45","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/dc09-1807","volume":"33","author":"C Kapitza","year":"2010","unstructured":"Kapitza C et al (2010) Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes. Diabetes Care 33(6):1288\u20131290","journal-title":"Diabetes Care"},{"issue":"1","key":"326_CR46","first-page":"55","volume":"10","author":"N Khalili","year":"2010","unstructured":"Khalili N et al (2010) Investigation of effect of oral insulin prepared from SPH and SPHC polymers in diabetic patients type I. J Diabetes Metab Disord 10(1):55\u201366","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"326_CR47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1463-1326.2009.01146.x","volume":"12","author":"S Luzio","year":"2010","unstructured":"Luzio S et al (2010) The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes. Diabetes Obes Metab 12(1):82\u201387","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"326_CR48","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.clinthera.2004.12.001","volume":"26","author":"S Cernea","year":"2004","unstructured":"Cernea S et al (2004) Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique. Clin Ther 26(12):2084\u20132091","journal-title":"Clin Ther"},{"issue":"10","key":"326_CR49","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.clinthera.2005.10.007","volume":"27","author":"S Cernea","year":"2005","unstructured":"Cernea S et al (2005) Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study. Clin Ther 27(10):1562\u20131570","journal-title":"Clin Ther"},{"issue":"3","key":"326_CR50","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1152\/ajpendo.1995.269.3.E443","volume":"32","author":"G Perriello","year":"1995","unstructured":"Perriello G et al (1995) Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle. Am J Physiol-Endocrinol Metabol 32(3):E443","journal-title":"Am J Physiol-Endocrinol Metabol"},{"issue":"4","key":"326_CR51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1534735403259152","volume":"2","author":"DB Boyd","year":"2003","unstructured":"Boyd DB (2003) Insulin and cancer. Integr Cancer Ther 2(4):315\u2013329","journal-title":"Integr Cancer Ther"},{"issue":"11","key":"326_CR52","doi-asserted-by":"crossref","first-page":"3109S","DOI":"10.1093\/jn\/131.11.3109S","volume":"131","author":"E Giovannucci","year":"2001","unstructured":"Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131(11):3109S\u20133120S","journal-title":"J Nutr"},{"issue":"2","key":"326_CR53","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s001250051393","volume":"40","author":"D Ish-Shalom","year":"1997","unstructured":"Ish-Shalom D et al (1997) Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40(2):S25\u2013S31","journal-title":"Diabetologia"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0326-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0326-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0326-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T20:28:46Z","timestamp":1748464126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0326-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0326-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}